Search results for "Fibrillation"

showing 10 items of 509 documents

P wave duration and risk of longitudinal atrial fibrillation in persons ≥ 60 years old (from the Framingham Heart Study).

2011

Long-term risk prediction is a priority for the prevention of atrial fibrillation (AF). P wave indices are electrocardiographic measurements describing atrial conduction. The role of P wave indices in the prospective determination of AF and mortality risk has had limited assessment. We quantified by digital caliper the P wave indices of maximum duration and dispersion in 1,550 Framingham Heart Study participants ≥ 60 years old (58% women) from single-channel electrocardiograms recorded from 1968 through 1971. We examined the association of selected P wave indices and long-term outcomes using Cox proportional hazards regression incorporating age, gender, body mass index, systolic blood press…

Malemedicine.medical_specialtyArticleElectrocardiographyFramingham Heart StudyPredictive Value of TestsRisk FactorsInternal medicineAtrial FibrillationMedicineHumansLongitudinal StudiesPR intervalRisk factorAgedProportional Hazards Modelsbusiness.industryProportional hazards modelIncidenceHazard ratioAtrial fibrillationMiddle Agedmedicine.diseaseConfidence intervalUnited StatesPhenotypeHeart failureCardiologyFemaleCardiology and Cardiovascular MedicinebusinessFollow-Up StudiesThe American journal of cardiology
researchProduct

Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.

2020

Background: Percutaneous left atrial appendage closure (LAAC) exposes to the risk of device thrombosis in patients with atrial fibrillation who frequently have a contraindication to full anticoagulation. Thereby, dual antiplatelet therapy (DAPT) is usually preferred. No randomized study has evaluated nonvitamin K antagonist oral anticoagulant after LAAC, and we decided to evaluate the efficacy and safety of reduced doses of rivaroxaban after LAAC. Methods: ADRIFT (Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure) is a multicenter, phase IIb study, which randomized 105 patients after successful LAAC to eith…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsAntithrombin IIIAtrial AppendagePilot Projects030204 cardiovascular system & hematologyFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRivaroxabanLeft atrialHeart RateInternal medicineAtrial FibrillationMedicineHumansAtrial Appendage030212 general & internal medicineContraindicationBlood CoagulationAgedAppendageAged 80 and overRivaroxabanbusiness.industryDual Anti-Platelet TherapyAtrial fibrillationThrombosisClopidogrelmedicine.diseasePeptide Fragments3. Good healthTreatment OutcomeCardiologyAtrial Function LeftFemaleProthrombinFranceCardiology and Cardiovascular MedicinebusinessBiomarkersPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsPeptide HydrolasesCirculation. Cardiovascular interventions
researchProduct

Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation

2009

Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the treatment of patients with atrial fibrillation (AF) and with a high risk of stroke who are not eligible for long-term anticoagulation therapy. The aim of this study was to asses the safety, feasibility, and long-term efficacy of this procedure. Methods: From July 2004 to June 2007, 20 patients (13 male, mean age 69 ± 8 years) with non–valvular AF (NV-AF) underwent LAA percutaneous closure using the PLAATO™ system, implanted through a transeptal access. All patients had contraindications to anticoagulant therapy and were at high risk for cardioembolic stroke (mean CHADS2 score 3 ± 1.2). A trans…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsThromboembolism.left atrial appendage occlusionmedicine.medical_treatmentEmbolismSettore MED/11 - Malattie dell'Apparato CardiovascolareTransesophagealLeft atrial appendage occlusionPericardial effusionRisk AssessmentLeft atrialInternal medicineAtrial FibrillationmedicineHumansRadiology Nuclear Medicine and imagingAtrial Appendageatrial fibrillation; left atrial appendage occlusion; thromboembolism; Aged; Atrial Fibrillation; Contraindications; Echocardiography Transesophageal; Embolism; Equipment Design; Feasibility Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Anticoagulants; Atrial Appendage; Cardiac Catheterization; Chronic DiseaseStrokeAgedbusiness.industryContraindicationsAnticoagulantsAtrial fibrillationGeneral MedicineEquipment DesignthromboembolismMiddle Agedmedicine.diseaseSurgeryStrokeTreatment OutcomePericardiocentesisEchocardiographyChronic DiseaseCardiologyPatent foramen ovaleFeasibility StudiesFemaleCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealPlatelet Aggregation Inhibitors
researchProduct

Standardized Model of Ventricular Fibrillation and Advanced Cardiac Life Support in Swine

2020

Cardiopulmonary resuscitation after cardiac arrest, independent of its origin, is a regularly encountered medical emergency in hospitals as well as preclinical settings. Prospective randomized trials in human subjects are difficult to design and ethically ambiguous, which results in a lack of evidence-based therapies. The model presented in this report represents one of the most common causes of cardiac arrests, ventricular fibrillation, in a standardized setting in a large animal model. This allows for reproducible observations and various therapeutic interventions under clinically accurate conditions, hence facilitating the generation of better evidence and eventually the potential for im…

Malemedicine.medical_specialtyCardiac outputResuscitationSwineGeneral Chemical Engineeringmedicine.medical_treatmentPsychological interventionMEDLINEAdvanced Cardiac Life SupportDecarboxylationGeneral Biochemistry Genetics and Molecular Biologylaw.invention03 medical and health sciences0302 clinical medicineRandomized controlled triallawmedicineAnimals030212 general & internal medicineCardiopulmonary resuscitationCardiac OutputIntensive care medicineGeneral Immunology and Microbiologybusiness.industryGeneral NeuroscienceAdvanced cardiac life support030208 emergency & critical care medicinemedicine.diseaseCardiopulmonary ResuscitationOxygenDisease Models AnimalVentricular FibrillationVentricular fibrillationbusinessJournal of Visualized Experiments
researchProduct

Choline Metabolism and Risk of Atrial Fibrillation and Heart Failure in the PREDIMED Study

2020

Abstract Background Few studies have examined the associations of trimethylamine-N-oxide (TMAO) and its precursors (choline, betaine, dimethylglycine, and L-carnitine) with the risk of atrial fibrillation (AF) and heart failure (HF). This study sought to investigate these associations. Methods Prospective associations of these metabolites with incident AF and HF were examined among participants at high cardiovascular risk in the PREDIMED study (PREvención con DIeta MEDiterránea) after follow-up for about 10 years. Two nested case-control studies were conducted, including 509 AF incident cases matched to 618 controls and 326 HF incident cases matched to 426 controls. Plasma levels of TMAO an…

Malemedicine.medical_specialtyClinical BiochemistryTrimethylamine N-oxide030204 cardiovascular system & hematologyGastroenterologyCholineDimethylglycineMethylamines03 medical and health scienceschemistry.chemical_compound0302 clinical medicineBetaineRisk FactorsCarnitineInternal medicineAtrial FibrillationmedicineHumansCholineProspective Studies030212 general & internal medicineAgedHeart Failurebusiness.industryBiochemistry (medical)SarcosineAtrial fibrillationArticlesOdds ratiomedicine.diseaseBetainechemistryQuartileCase-Control StudiesHeart failureFemalebusinessClinical Chemistry
researchProduct

Detection of Myocardial Infarction by Cardiac Magnetic Resonance in Embolic Stroke Related to First Diagnosed Atrial Fibrillation

2021

Elevated troponin levels are found in a significant number of patients who are diagnosed with acute embolic stroke (AES) after first diagnosed atrial fibrillation (AF). These myocardial injuries, which are known as cardiocerebral infarction (CCI), are potentially caused by coronary embolism and correspond to simultaneous cardiac and cerebral embolisms. However, this severe condition remains poorly understood. In this prospective study, we aimed to investigate the prevalence and the cardiac magnetic resonance (CMR) characteristics of CCI.Consecutive patients with first diagnosed AF hospitalized for AES in a neurovascular intensive care unit from 2019 to 2020 were included. Troponin Ic kineti…

Malemedicine.medical_specialtyComputed Tomography Angiographymedicine.medical_treatmentMyocardial InfarctionMagnetic Resonance Imaging CineInfarctionCoronary Angiographylaw.inventionElectrocardiography03 medical and health sciences0302 clinical medicinePredictive Value of TestslawInternal medicineAtrial FibrillationPrevalenceHumansMedicineProspective Studiescardiovascular diseasesMyocardial infarctionEmbolizationProspective cohort studyAgedAged 80 and overEmbolic Strokebiologybusiness.industryTroponin IRehabilitationAtrial fibrillationMiddle AgedNeurovascular bundlemedicine.diseaseIntensive care unitTroponinUp-Regulationbiology.proteinCardiologyFemaleSurgeryFranceNeurology (clinical)Cardiology and Cardiovascular MedicinebusinessBiomarkers030217 neurology & neurosurgeryJournal of Stroke and Cerebrovascular Diseases
researchProduct

History of deep vein thrombosis is a discriminator for concomitant atrial fibrillation in pulmonary embolism.

2015

Pulmonary embolism (PE) is the consequence of deep vein thrombosis (DVT) in 70% of all cases. Although, PE and DVT are commonly related to risk factors of Virchow's triad, both entities are linked to cardiovascular risk factors, but risk factors seem differently important in both entities.We aimed to investigate clinical profile and outcome of patients with PE history stratified by concomitant DVT.Data from the observational multi-center thrombEVAL-study were analyzed.The sample (N=2,318) comprised 295 PE patients, of whom 69.2% (N=204) had DVT. Individuals without DVT were older and had higher prevalence of concomitant atrial fibrillation (AF), chronic lung diseases, coronary artery diseas…

Malemedicine.medical_specialtyDeep veinCoronary artery diseaseRisk FactorsInternal medicineAtrial FibrillationmedicineHumanscardiovascular diseasesAgedAged 80 and overVenous Thrombosisbusiness.industryAtrial fibrillationHematologyOdds ratiomedicine.diseaseThrombosisPulmonary embolismVenous thrombosismedicine.anatomical_structureHeart failureCardiologyFemalebusinessPulmonary EmbolismThrombosis research
researchProduct

ICD Implantation in infants and small children: the extracardiac technique.

2007

There is no clear methodology for implantation of an internal cardioverter-defibrillator (ICD) in infants and small children. The aim of this study was to assess efficacy and safety of an extracardiac ICD implantation technique in pediatric patients.An extracardiac ICD system was implanted in eight patients (age: 0.3-8 years; body weight: 4-29 kg). Under fluoroscopic guidance a defibrillator lead was tunneled subcutaneously starting from the anterior axillar line along the course of the 6th rib until almost reaching the vertebral column. After a partial inferior sternotomy, bipolar steroid-eluting sensing and pacing leads were sutured to the atrial wall (n = 2) and to the anterior wall of t…

Malemedicine.medical_specialtyDefibrillationmedicine.medical_treatmentAnterior wallElectric Countershock030204 cardiovascular system & hematologyProsthesis Implantation03 medical and health sciences0302 clinical medicinemedicineHumans030212 general & internal medicineLead (electronics)Childbusiness.industrySmall childrenInfantArrhythmias CardiacGeneral MedicineImplantable cardioverter-defibrillator3. Good healthIcd implantationSurgeryDefibrillators Implantablemedicine.anatomical_structureTreatment OutcomeVentricleChild PreschoolFemaleCardiology and Cardiovascular MedicinebusinessVertebral columnPacing and clinical electrophysiology : PACE
researchProduct

Atrial fibrillation in highly trained endurance athletes — Description of a syndrome

2016

Atrial fibrillation (AF) is the most common heart arrhythmia, the risk of which typically increases with age. This condition is commonly associated with major cardiovascular diseases and structural heart damage, while it is rarely observed in healthy young people. However, increasing evidence indicates that paroxysmal AF can also onset in young or middle-aged and otherwise healthy endurance athletes (e.g., cyclists, runners and cross-country skiers). Here we review the topic of AF associated with strenuous endurance exercise (SEE), for example cycling, running and cross-country skiing, especially at a competitive level, and we propose the definition of a new syndrome based on the accumulati…

Malemedicine.medical_specialtyExercise Endurance Arrhythmias Fibrosis Remodeling Left atriumEnfermedad cardiovascularLeft atriumArritmia030204 cardiovascular system & hematologyArrhythmiasEndurance03 medical and health sciencesSex Factors0302 clinical medicineHeart arrhythmiaRisk FactorsSex factorsEndurance trainingAtrial FibrillationmedicineHumans030212 general & internal medicineExerciseParoxysmal AFSistema cardiovascularVentricular RemodelingbiologyAthletesbusiness.industryAge FactorsAtrial fibrillationSyndromemedicine.diseasebiology.organism_classificationFibrosisRemodelingmedicine.anatomical_structureAthletesLeft atriumPhysical EndurancePhysical therapyCorazón - EnfermedadesFemaleCardiology and Cardiovascular Medicinebusinesshuman activitiesHeart damage
researchProduct

Postoperative Costs Associated With Outcomes After Cardiac Surgery With Extracorporeal Circulation: Role of Antithrombin Levels

2012

Objective: To study the impact on postoperative costs of a patient's antithrombin levels associated with outcomes after cardiac surgery with extracorporeal circulation. Design: An analytic decision model was designed to estimate costs and clinical outcomes after cardiac surgery in a typical patient with low antithrombin levels (= 63.7%). The data used in the model were obtained from a literature review and subsequently validated by a panel of experts in cardiothoracic anesthesiology. Setting: Multi-institutional (14 Spanish hospitals). Participants: Consultant anesthesiologists. Measurements and Main Results: A sensitivity analysis of extreme scenarios was carried out to assess the impact o…

Malemedicine.medical_specialtyExtracorporeal Circulationextracorporeal circulationCardiotonic AgentsMyocardial InfarctionAntithrombinsDrug Costslaw.inventionPostoperative ComplicationsDrug TherapylawSurveys and QuestionnairesThromboembolismAtrial FibrillationmedicineCardiopulmonary bypassHumansBlood TransfusionCardiac Surgical ProceduresCardiothoracic anesthesiologyAverage costAgedPostoperative Carebusiness.industryAntithrombinExtracorporeal circulationDecision TreesAntithrombin ActivityLength of StayMiddle AgedSurgeryCardiac surgeryStrokeIntensive Care UnitsantithrombinAnesthesiology and Pain MedicineTreatment OutcomeSpainHealth Care SurveysEmergency medicineCosts and Cost AnalysisFemaleKidney DiseasesCardiology and Cardiovascular Medicinebusinesscardiopulmonary bypassHospital staymedicine.drug
researchProduct